Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
| Business Activity | PASS |
| Debt Ratio (0.42%) | FAIL |
| Cash Ratio (0.96%) | FAIL |
| Receivables Ratio (0.00%) | PASS |
| Revenue Ratio (0.00%) | PASS |
| Overall | FAIL |
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2025-03-17 | 0.23 | 0.22 | -2.2% |
| 2022-11-03 | 0.19 | 0.23 | +23.8% |
| 2022-08-04 | 0.15 | 0.18 | +21.6% |
| 2022-05-05 | 0.19 | 0.13 | -32.8% |
| 2022-02-24 | 0.32 | 0.79 | +149.1% |
| 2021-11-04 | 0.19 | 0.27 | +44.3% |
| 2021-08-05 | 0.17 | 0.23 | +32.3% |
| 2021-04-29 | 0.15 | 0.19 | +23.6% |
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-05-01 | JACOBSON ERIC L | General Counsel | 75,000 | -- |
| 2026-04-01 | SYED TEHSIN M | Officer | 220,986 | -- |
| 2026-04-01 | BAKER TALLY | Officer | 110,493 | -- |
| 2026-04-01 | TRIGG DONALD | Chief Executive Officer | 552,465 | -- |
| 2025-11-03 | SYED TEHSIN M | Chief Technology Officer | 423,998 | -- |
| 2025-11-03 | BAKER TALLY | Officer | 105,999 | -- |
| 2025-09-02 | TRIGG DONALD | Chief Executive Officer | 571,428 | $3.0M |
| 2025-06-02 | FELT BRUCE C. JR. | Director | 46,512 | $200.0K |
| 2025-06-02 | ASAR VINIT K. | Director | 46,512 | $200.0K |
| 2025-06-02 | STEVENS DAVID B | Director | 46,512 | $200.0K |
| Holder | Shares | Value | % Held |
|---|---|---|---|
| FNY Investment Advisers, LLC | 13.0K | $61.6K | 0.0% |
| Huntington National Bank | 1.0 | $4.0 | — |
$240.5M
0.49
0.524
3
$588.0M
$218.8M
-1.8%
3.92
2,450
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2025-03-17 | $0.23 | $0.22 | -2.2% |
| 2022-11-03 | $0.19 | $0.23 | +23.8% |
| 2022-08-04 | $0.15 | $0.18 | +21.6% |
| 2022-05-05 | $0.19 | $0.13 | -32.8% |
| 2022-02-24 | $0.32 | $0.79 | +149.1% |
| 2021-11-04 | $0.19 | $0.27 | +44.3% |
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($5.83, 3 analysts) | |||
| 10 | $47.40 | +$10.90 (23%) | 1.5R |
| 50 | $237.00 | +$54.50 (23%) | 1.5R |
| 100 | $474.00 | +$109.00 (23%) | 1.5R |
| To Fair Value ($4.35) | |||
| 10 | $47.40 | +$-3.90 (-8%) | -0.5R |
| 50 | $237.00 | +$-19.50 (-8%) | -0.5R |
| 100 | $474.00 | +$-39.00 (-8%) | -0.5R |
- Elevated short interest (3.92 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| VSTS | 0.182 |
| IPG.KW | 0.159 |
| HURN | 0.153 |
| TTWO | 0.151 |
| CAH | 0.151 |
| Ticker | Correlation |
|---|---|
| LPTVQ | -0.192 |
| 6701.T | -0.167 |
| FLY | -0.164 |
| UPL.NS | -0.159 |
| 7202.SR | -0.155 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.